BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
Rhea-AI Summary
Bio-Techne (NASDAQ: TECH) has announced its participation in the Citi 2024 Global Healthcare Conference. Kim Kelderman, President and Chief Executive Officer, will deliver a presentation on Wednesday, December 4, 2024, at 3:15 p.m. EST. Interested parties can access a live webcast of the presentation through the IR Calendar page on Bio-Techne's Investor Relations website.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, TECH gained 0.68%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
Contact: | David Clair, Vice President, Investor Relations & Corporate Development |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-citi-2024-global-healthcare-conference-302316680.html
SOURCE Bio-Techne Corporation
